510(k) Report

510(k) · Cleared

Cleared

OCT-Camera ID 21101A3

K200516510(k) TraditionalCleared Sep 2, 2020184-day reviewClass II21 CFR 886.1570

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Optomedical Technologies GmbH · OBO Tomography, Optical Coherence

Cleared on Sep 2, 2020 as substantially equivalent to K142953 (Optomedical Technologies GmbH, 2015) after a 184-day review. Its family tree reaches back 6 generations to 2002.

Decided
Sep 2, 2020
Review
184 days
Class
Class II
Product code
OBO
Recalls
None
Predicates
1

Its longest line of descent runs back 6 generations to K012727 (2002). No later device cites it as a predicate yet.

  1. Root · 6 generations backK012727 Humphrey OCT3Carl Zeiss Ophthalmic Systems, Inc. · 2002
  2. 5 generations backK030433 Stratusoct with RNFL Normative DatabaseCarl Zeiss Meditec, Inc. · 2003 · Recalled
  3. 4 generations backK033123 Stratusoct with RNFL & Macula Normative DatabaseCarl Zeiss Meditec, Inc. · 2004 · Recalled
  4. 3 generations backK063343 Bioptigen Spectral Domain Ophthalmic Imaging SystemBioptigen, Inc. · 2006
  5. 2 generations backK120057 Envisu Spectral Domain Ophthalmic Imaging System (Sdois)Bioptigen, Inc. · 2012
  6. 1 generation backK142953 OCT-CameraOptomedical Technologies GmbH · 2015 · Recalled
  7. This deviceK200516 OCT-Camera ID 21101A3Optomedical Technologies GmbH · 2020
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−6K012727Humphrey OCT3Carl Zeiss Ophthalmic Systems, Inc.2002—
−5K030433Stratusoct with RNFL Normative DatabaseCarl Zeiss Meditec, Inc.20031
−4K033123Stratusoct with RNFL & Macula Normative DatabaseCarl Zeiss Meditec, Inc.20041
−3K063343Bioptigen Spectral Domain Ophthalmic Imaging SystemBioptigen, Inc.2006—
−2K120057Envisu Spectral Domain Ophthalmic Imaging System (Sdois)Bioptigen, Inc.2012—
−1K142953OCT-CameraOptomedical Technologies GmbH20152
0 (this device)K200516OCT-Camera ID 21101A3Optomedical Technologies GmbH2020—
FIG. 1 — Lineage of K200516, 2002–2020Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in OBO? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new OBO device

  1. #1 K250868 SPECTRALIS HRA+OCT and variantsscore 16.2 · 14 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K142953OCT-Camera
Summary page 5
…Class: Class II Classification Panel: Ophthalmic Section 5 Page 1 of 5 5. Legally Marketed Predicate Device K142953, OCT-Camera (ID21101A1), OptoMedical Technologies GmbH, GERMANY 6. Indication for Use Statement OptoMedical Technologies OCT-…
Optomedical Technologies GmbH20152

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 18 years and passes through 4 companies; a new generation was cleared every 2.8 years on median.
  • 3 of the 6 ancestors have a recall of any class.

How does its category compare?

All OBO devices

OBO Tomography, Optical Coherence: FDA decisions, review times, recalls and adverse event reports over 20 years. 2020, this device’s year, is highlighted.

FDA decisions per year · OBO

3in 2025

2007: 22008: 22009: 42010: 22011: 22012: 32013: 22014: 32015: 12016: 42017: 42018: 62019: 52020: 22021: 12022: 22023: 72024: 82025: 32026 (partial year): 2
2007high 8 (2024) · low 1 (2015)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · OBO

125in 2025

2009: 151 days median2012: 269 days median2014: 152 days median2016: 125 days median2017: 118 days median2018: 87 days median2019: 249 days median2023: 262 days median2024: 157 days median2025: 125 days median
2007high 269 (2012) · low 87 (2018)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · OBO

1in 2022

2010: 12011: 22012: 22018: 12021: 12022: 12026 (partial year): 1
2007high 2 (2011) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · OBO

4in 2025

2013: 22016: 12018: 12021: 12023: 32024: 32025: 4
2007high 4 (2025) · low 0 (2007)2025

MAUDE reports naming product code OBO, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—00
20082—00
2009415100
20102—10
20112—20
2012326920
20132—02
2014315200
20151—00
2016412501
2017411800
201868711
2019524900
20202—00
20211—11
20222—10
2023726203
2024815703
2025312504
20262—1—

What is it indicated for?

OptoMedical Technologies OCT-Camera ID 21101A3 is intended to acquire, process, display and save depth-resolved images of ocular tissue microstructure using Spectral Domain Optical Coherence Tomography (SD-OCT). The OCT-Camera ID 21101A3 is indicated for the use as an aid in the diagnosis of physiologic and pathologic conditions of the eye through non-contact optical imaging. Imaging of the various tissues of the eye is supported through the use of…

Read the full statement (119 words)

OptoMedical Technologies OCT-Camera ID 21101A3 is intended to acquire, process, display and save depth-resolved images of ocular tissue microstructure using Spectral Domain Optical Coherence Tomography (SD-OCT). The OCT-Camera ID 21101A3 is indicated for the use as an aid in the diagnosis of physiologic and pathologic conditions of the eye through non-contact optical imaging. Imaging of the various tissues of the eye is supported through the use of interchangeable lenses. It is indicated for use on all patient populations except premature and neonatal infants, and is suitable for patients ambulatory or confined. The system is indicated for use in supine imaging, mounted to the surgical microscope HS Hi‐R NEO 900A NIR (Haag‐Streit), and is suited for imaging patients under anesthesia.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K200516: OCT-Camera ID 21101A3.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 3, 2026. https://510kreport.com/device/K200516

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026